The Oncology Nursing Society (ONS) recently published interim guidelines – though they’re admittedly not ideal – on PPE usage in the midst of the epidemic.
Nurses and other healthcare professionals are facing personal protective equipment (PPE) shortages across the nation due to the coronavirus disease 2019 (COVID-19). The Oncology Nursing Society (ONS) recently published interim guidelines on PPE usage in the midst of the pandemic.
“Although ONS supports full protection of healthcare workers handling drugs for cancer treatment that the National Institute for Occupational Safety and Health (NIOSH) has deemed hazardous, nurses in clinical settings are facing difficult choices if recommended PPE supplies are not available,” ONS said in a statement. “In addition, they are making choices regarding the protection of themselves and their patients from potential COVID-19 infection and use of PPE for safe handling of hazardous cancer drugs.”
The society said that they support recommendations that prioritize the protection of healthcare workers and patients from COVID-19, and when it comes to treating patients with the virus, ONS recommends following guidelines set by the Centers for Disease Control and Prevention (CDC).
But when it comes to handling chemotherapy and other hazardous cancer drugs (based on the Table 1 NIOSH List), ONS published guidelines for nurses to follow during the COVID-19 outbreak. The guidelines follow a most- to least-recommended use of gowns, masks, eye protection, gloves, and shoe covers.
“Although ONS recognizes that these are not ideal, they are interim guidelines to support decision making and staff and patient safety in clinical care during the COVID-19 pandemic,” the statement said.
ONS recommendation
If recommendation is not available
Third choice
Gowns
Disposable poly-coated gown
Regular, water-resistant, disposable gown
Cloth gown (facility laundered) for infection control and non-hazardous drugs
Masks
Mask with face and eye protection only if splashing is likely or for spill cleanup
Reserve N95s for symptomatic/COVID-positive patients, hazardous drug spills, and cleanup
Powered air purifying respirators (PARS)
Eye Protection
Mask with eye protection or goggles if splashing is likely/spill cleanup
Full-facepiece air purifying respirators or PARS
Gloves
Double chemotherapy-tested gloves
Single chemotherapy-tested gloves
Double standard exam gloves
Shoe covers
Use only in area for compounding hazardous drugs
Work-only, washable shoes
“Evaluate workflows and processes to maximize efficiency and decrease waste of PPE supplies. Cluster care activities as much as possible and avoid touch contamination of surfaces,” the statement says.
Read more on the Coronavirus (COVID-19):
FDA Approves Encorafenib Plus Cetuximab and Chemo in BRAF V600E-Positive Metastatic CRC
Published: December 20th 2024 | Updated: December 20th 2024The FDA has granted approval for the use of encorafenib in combination with cetuximab and mFOLFOX6 for the treatment of metastatic colorectal cancer harboring a BRAF V600E mutation.